Skip to main content
Veterinary Medicines

Lincomycine 40 % VMD Pulvis 400 mg/ml Poeder voor gebruik in drinkwater

Authorised
  • Lincomycin hydrochloride

Product identification

Medicine name:
Lincomycine 40 % VMD Pulvis 400 mg/ml Poeder voor gebruik in drinkwater
Lincomycine 40 % VMD Pulvis 400 mg/ml Poudre pour administration dans l’eau de boisson
Lincomycine 40 % VMD Pulvis 400 mg/ml Pulver zum Eingeben über das Trinkwasser
Active substance:
  • Lincomycin hydrochloride
Target species:
  • Pig
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Lincomycin hydrochloride
    435.90
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Powder for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Pig
      • Meat and offal
        1
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF02
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Lincomycine 40 % VMD Pulvis Jar with 1.5 kg Powder for use in drinking water
  • Lincomycine 40 % VMD Pulvis Jar with 150 g Powder for use in drinking water

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V192175
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
French (PDF)
Published on: 22/03/2022
German (PDF)
Published on: 22/03/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."